HCA Healthcare, Inc.

1. 01

   Behind SPY and its sector fund XLV over 1 year

   1 month: +6.4% (SPY −2.6%, XLV +9.9%). 3 months: +15.5% (SPY −2.2%, XLV +13.5%). 1 year: +0.3% (SPY +10.4%, XLV +27.4%). Price change to the 3 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: HCA, SPY and XLV · as of 3 Nov 2026

2. 02

   Above its 50- and 200-day averages

   The 3 Nov 2026 close of $462.86 was 5.5% above its 50-day average ($438.86) and 4.2% above its 200-day average ($444.28). It has closed above the 200-day for 18 sessions, since 9 Oct 2026. The 50-day average crossed below the 200-day on 22 May 2026, 113 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 3 Nov 2026

3. 03

   Next ex-dividend date: 15 Dec 2026

   $0.78 a share, payable 29 Dec 2026; unchanged from the previous payment (ex-date 16 Sep 2026).

   Corporate actions record · as of 4 Nov 2026

4. 04

   54% of the way up its 52-week range

   Closed at $462.86 on 3 Nov 2026: 16.8% below the 52-week high of $556.52 (12 Mar 2026) and 30.8% above the low of $353.99 (14 Jul 2026).

   Daily price bars, split-adjusted · as of 3 Nov 2026

5. 05

   Short interest at 2.3% of shares outstanding

   4.9M shares were sold short at the 15 Oct 2026 settlement, 2.3% of the 208.9M shares outstanding; covering them would take 4.6 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

At the 3 Nov 2026 close